Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03173014
Other study ID # 1705-013-851
Secondary ID
Status Recruiting
Phase N/A
First received May 30, 2017
Last updated July 18, 2017
Start date June 30, 2017
Est. completion date June 5, 2018

Study information

Verified date July 2017
Source Seoul National University Hospital
Contact Hee-Soo Kim
Phone 1052878006
Email dami0605@snu.ac.kr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

EEG in moyamoya disease in children preoperatively


Description:

EEG monitoring in children with moyamoy disease preoperatively for 10 minutes


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date June 5, 2018
Est. primary completion date May 30, 2018
Accepts healthy volunteers No
Gender All
Age group 5 Years to 10 Years
Eligibility Inclusion Criteria:

- moyamoya disease

Exclusion Criteria:

- refusal

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EEG
EEG monitoring

Locations

Country Name City State
Korea, Republic of Hee-Soo Kim Seoul Soul-t'ukpyolsi
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary EEG EEG finding preoperative
See also
  Status Clinical Trial Phase
Recruiting NCT04219033 - Postoperative Cognitive Function and EEG
Active, not recruiting NCT05188833 - EEG Results of Deep TMS in Patients With OCD N/A
Recruiting NCT05257096 - Performance of EEG in Children With Medical Clowns N/A
Not yet recruiting NCT05123469 - Clinical Validation of zEEG, a Wireless EEG Recording System for Pediatric and Adult Patients With Epilepsy
Not yet recruiting NCT06133842 - CEReBral AutorEgulation in Non-cardiac SuRgery and Relationship to Postoperative DeliriUm State
Completed NCT03129438 - Continuous EEG Randomized Trial in Adults N/A
Not yet recruiting NCT06352372 - Safety and Efficacy of tPBM for Epileptiform Activity in Autism Phase 2
Enrolling by invitation NCT06368726 - Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders Phase 1